Fulgent Genetics, Inc. (FLGT) › Operating Cash FlowFulgent Genetics, Inc. (FLGT) — Operating Cash FlowAnnual figures by period end, from SEC filings.2014-12-31: -$4.40M2015-12-31: -$969.0K2016-12-31: $4.41M2017-12-31: $1.33M2018-12-31: -$675.0K2019-12-31: $5.52M2020-12-31: $140.63M2021-12-31: $538.58M2022-12-31: $253.52M2023-12-31: $27.00M2024-12-31: $21.06M2025-12-31: -$101.64M-$101.64M2014-12-31Operating Cash Flow (USD)2025-12-31Period endedOperating Cash FlowChange YoYSource filing2025-12-31-$101.64M-582.6%2026-02-27From 2025-01-012024-12-31$21.06M-22.0%2026-02-27From 2024-01-012023-12-31$27.00M-89.3%2026-02-27From 2023-01-012022-12-31$253.52M-52.9%2025-02-28From 2022-01-012021-12-31$538.58M+283.0%2024-02-28From 2021-01-012020-12-31$140.63M+2449.0%2023-02-28From 2020-01-012019-12-31$5.52M—2022-02-28From 2019-01-012018-12-31-$675.0K-150.7%2020-03-13From 2018-01-012017-12-31$1.33M-69.8%2019-03-22From 2017-01-012016-12-31$4.41M—2018-03-20From 2016-01-012015-12-31-$969.0K—2017-03-17From 2015-01-012014-12-31-$4.40M—2017-03-17From 2014-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)